scholarly journals Including pork in the Mediterranean diet for an Australian population: Protocol for a randomised controlled trial assessing cardiovascular risk and cognitive function

2017 ◽  
Vol 16 (1) ◽  
Author(s):  
Alexandra T. Wade ◽  
Courtney R. Davis ◽  
Kathryn A. Dyer ◽  
Jonathan M. Hodgson ◽  
Richard J. Woodman ◽  
...  
Nutrients ◽  
2016 ◽  
Vol 8 (9) ◽  
pp. 579 ◽  
Author(s):  
Alissa Knight ◽  
Janet Bryan ◽  
Carlene Wilson ◽  
Jonathan Hodgson ◽  
Courtney Davis ◽  
...  

2019 ◽  
Vol 12 (2) ◽  
pp. 153-161 ◽  
Author(s):  
Ana Molina Jimenez ◽  
Sara Lopez Oliva ◽  
Elena Garicano Vilar ◽  
Begoña de Cuevillas ◽  
Maria del Carmen Morais Moreno ◽  
...  

Author(s):  
Aristea Gioxari ◽  
Dimitrios Tzanos ◽  
Christina Kostara ◽  
Panos Papandreou ◽  
Giannis Mountzios ◽  
...  

The Mediterranean diet (MD) has been inversely associated with lung cancer (LC) risk. Hereby we show the preliminary results of our prospective randomised controlled trial in inflammatory and nutritional status of LC patients after 3-month implementation of MD. In total, 30 patients with small-cell or non-small-cell LC (stages III–IV) were enrolled. They were randomly assigned either to Control group, receiving general nutritional guidelines, or the MD group, in which a personalised MD plan was provided. Medical and dietary history, anthropometrics, blood biomarkers, and circulating antioxidant vitamins were assessed. The main outcome was a significantly higher advanced lung cancer inflammation index (ALI) in patients of the control arm than those following MD (p = 0.003). In the MD group, platelets were significantly reduced at the study endpoint (p = 0.044). BMI and body fat mass remained unchanged in both arms, but serum glucose was significantly higher in control compared to MD group (p = 0.017). In conclusion, we showed for the first time that implementing a personalised MD for 3 months is promising to regulate prognostic biomarkers in advanced LC. The final results of our on-going trial will shed a light on the inflammatory, antioxidant and nutritional status of LC patients following MD.


2009 ◽  
Vol 69 (1) ◽  
pp. 45-60 ◽  
Author(s):  
Pascal P. McKeown ◽  
Karen Logan ◽  
Michelle C. McKinley ◽  
Ian S. Young ◽  
Jayne V. Woodside

Diet is associated with the development of CHD. The incidence of CHD is lower in southern European countries than in northern European countries and it has been proposed that this difference may be a result of diet. The traditional Mediterranean diet emphasises a high intake of fruits, vegetables, bread, other forms of cereals, potatoes, beans, nuts and seeds. It includes olive oil as a major fat source and dairy products, fish and poultry are consumed in low to moderate amounts. Many observational studies have shown that the Mediterranean diet is associated with reduced risk of CHD, and this result has been confirmed by meta-analysis, while a single randomised controlled trial, the Lyon Diet Heart study, has shown a reduction in CHD risk in subjects following the Mediterranean diet in the secondary prevention setting. However, it is uncertain whether the benefits of the Mediterranean diet are transferable to other non-Mediterranean populations and whether the effects of the Mediterranean diet will still be feasible in light of the changes in pharmacological therapy seen in patients with CHD since the Lyon Diet Heart study was conducted. Further randomised controlled trials are required and if the risk-reducing effect is confirmed then the best methods to effectively deliver this public health message worldwide need to be considered.


Sign in / Sign up

Export Citation Format

Share Document